Initially, prostate cancer requires androgens such as testosterone, or the more potent dihydrotestosterone (DHT), for growth and is therefore referred to as androgen dependent.[2] Steroidal androgens exert their effects by binding to the androgen receptor (AR) in the cytoplasm of cells promoting nuclear translocation. Here, AR is linked to prostate cancer.